A citation-based method for searching scientific literature

Rodica Pop-Busui, Andrew J M Boulton, Eva L Feldman, Vera Bril, Roy Freeman, Rayaz A Malik, Jay M Sosenko, Dan Ziegler. Diabetes Care 2017
Times Cited: 601







List of co-cited articles
661 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments.
Solomon Tesfaye, Andrew J M Boulton, Peter J Dyck, Roy Freeman, Michael Horowitz, Peter Kempler, Giuseppe Lauria, Rayaz A Malik, Vincenza Spallone, Aaron Vinik,[...]. Diabetes Care 2010
22

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.
Faramarz Ismail-Beigi, Timothy Craven, Mary Ann Banerji, Jan Basile, Jorge Calles, Robert M Cohen, Robert Cuddihy, William C Cushman, Saul Genuth, Richard H Grimm,[...]. Lancet 2010
807
13





Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management.
Vincenza Spallone, Dan Ziegler, Roy Freeman, Luciano Bernardi, Simona Frontoni, Rodica Pop-Busui, Martin Stevens, Peter Kempler, Jannik Hilsted, Solomon Tesfaye,[...]. Diabetes Metab Res Rev 2011
414
9

Emerging Biomarkers, Tools, and Treatments for Diabetic Polyneuropathy.
Gidon J Bönhof, Christian Herder, Alexander Strom, Nikolaos Papanas, Michael Roden, Dan Ziegler. Endocr Rev 2019
63
14

Enhanced glucose control for preventing and treating diabetic neuropathy.
Brian C Callaghan, Ann A Little, Eva L Feldman, Richard A C Hughes. Cochrane Database Syst Rev 2012
247
9


Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
8

Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
Rodica Pop-Busui, Gregory W Evans, Hertzel C Gerstein, Vivian Fonseca, Jerome L Fleg, Byron J Hoogwerf, Saul Genuth, Richard H Grimm, Marshall A Corson, Ronald Prineas. Diabetes Care 2010
267
8

Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial.
Dan Ziegler, Phillip A Low, William J Litchy, Andrew J M Boulton, Aaron I Vinik, Roy Freeman, Rustem Samigullin, Hans Tritschler, Ullrich Munzel, Joachim Maus,[...]. Diabetes Care 2011
189
7

Vascular risk factors and diabetic neuropathy.
Solomon Tesfaye, Nish Chaturvedi, Simon E M Eaton, John D Ward, Christos Manes, Constantin Ionescu-Tirgoviste, Daniel R Witte, John H Fuller. N Engl J Med 2005
745
7

Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort.
Rodica Pop-Busui, Jiang Lu, Maria Mori Brooks, Stewart Albert, Andrew D Althouse, Jorge Escobedo, Jenifer Green, Pasquale Palumbo, Bruce A Perkins, Fred Whitehouse,[...]. Diabetes Care 2013
76
9

Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K.
Caroline A Abbott, Rayaz A Malik, Ernest R E van Ross, Jai Kulkarni, Andrew J M Boulton. Diabetes Care 2011
384
7

Epidemiology of polyneuropathy in diabetes and prediabetes.
Dan Ziegler, Nikolaos Papanas, Aaron I Vinik, Jonathan E Shaw. Handb Clin Neurol 2014
96
7


Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.
Peter Gaede, Pernille Vedel, Nicolai Larsen, Gunnar V H Jensen, Hans-Henrik Parving, Oluf Pedersen. N Engl J Med 2003
6


Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study.
H Stracke, W Gaus, U Achenbach, K Federlin, R G Bretzel. Exp Clin Endocrinol Diabetes 2008
81
7

Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.
Dan Ziegler, Alexander Ametov, Alexey Barinov, Peter J Dyck, Irina Gurieva, Phillip A Low, Ullrich Munzel, Nikolai Yakhno, Itamar Raz, Maria Novosadova,[...]. Diabetes Care 2006
311
6


Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Pouya Saeedi, Inga Petersohn, Paraskevi Salpea, Belma Malanda, Suvi Karuranga, Nigel Unwin, Stephen Colagiuri, Leonor Guariguata, Ayesha A Motala, Katherine Ogurtsova,[...]. Diabetes Res Clin Pract 2019
6

Lifestyle intervention for pre-diabetic neuropathy.
A Gordon Smith, James Russell, Eva L Feldman, Jonathan Goldstein, Amanda Peltier, Sheldon Smith, Jouhaina Hamwi, Donald Pollari, Billie Bixby, James Howard,[...]. Diabetes Care 2006
339
6

Obesity and hyperlipidemia are risk factors for early diabetic neuropathy.
A Gordon Smith, J Robinson Singleton. J Diabetes Complications 2013
115
6

Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy.
Hans-Peter Hammes, Xueliang Du, Diane Edelstein, Tetsuya Taguchi, Takeshi Matsumura, Qida Ju, Jihong Lin, Angelika Bierhaus, Peter Nawroth, Dieter Hannak,[...]. Nat Med 2003
531
6

Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.
Nanna B Finnerup, Nadine Attal, Simon Haroutounian, Ewan McNicol, Ralf Baron, Robert H Dworkin, Ian Gilron, Maija Haanpää, Per Hansson, Troels S Jensen,[...]. Lancet Neurol 2015
6

The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy.
Patricia M Kluding, Mamatha Pasnoor, Rupali Singh, Stephen Jernigan, Kevin Farmer, Jason Rucker, Neena K Sharma, Douglas E Wright. J Diabetes Complications 2012
151
6

Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young Adulthood.
Dana Dabelea, Jeanette M Stafford, Elizabeth J Mayer-Davis, Ralph D'Agostino, Lawrence Dolan, Giuseppina Imperatore, Barbara Linder, Jean M Lawrence, Santica M Marcovina, Amy K Mottl,[...]. JAMA 2017
224
6

10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
6

Diabetic neuropathy.
Eva L Feldman, Brian C Callaghan, Rodica Pop-Busui, Douglas W Zochodne, Douglas E Wright, David L Bennett, Vera Bril, James W Russell, Vijay Viswanathan. Nat Rev Dis Primers 2019
145
6

New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain.
Eva L Feldman, Klaus-Armin Nave, Troels S Jensen, David L H Bennett. Neuron 2017
257
6

Glucose control and diabetic neuropathy: lessons from recent large clinical trials.
Lynn Ang, Mamta Jaiswal, Catherine Martin, Rodica Pop-Busui. Curr Diab Rep 2014
102
6

Diabetic cardiovascular autonomic neuropathy.
Aaron I Vinik, Dan Ziegler. Circulation 2007
650
6

Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study.
S Tesfaye, L K Stevens, J M Stephenson, J H Fuller, M Plater, C Ionescu-Tirgoviste, A Nuber, G Pozza, J D Ward. Diabetologia 1996
394
6

Inflammation as a Therapeutic Target for Diabetic Neuropathies.
Rodica Pop-Busui, Lynn Ang, Crystal Holmes, Katherine Gallagher, Eva L Feldman. Curr Diab Rep 2016
91
6

Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain.
Solomon Tesfaye, Stefan Wilhelm, Alberto Lledo, Alexander Schacht, Thomas Tölle, Didier Bouhassira, Giorgio Cruccu, Vladimir Skljarevski, Rainer Freynhagen. Pain 2013
134
5

Aldose reductase inhibitors for the treatment of diabetic polyneuropathy.
C Chalk, T J Benstead, F Moore. Cochrane Database Syst Rev 2007
76
6

The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis.
Raelene E Maser, Braxton D Mitchell, Aaron I Vinik, Roy Freeman. Diabetes Care 2003
389
5

Diabetic autonomic neuropathy.
Aaron I Vinik, Raelene E Maser, Braxton D Mitchell, Roy Freeman. Diabetes Care 2003
5

Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study.
James W Albers, William H Herman, Rodica Pop-Busui, Eva L Feldman, Catherine L Martin, Patricia A Cleary, Barbara H Waberski, John M Lachin. Diabetes Care 2010
207
5


Diabetic neuropathy differs between type 1 and type 2 diabetes: Insights from magnetic resonance neurography.
Johann M E Jende, Jan B Groener, Dimitrios Oikonomou, Sabine Heiland, Stefan Kopf, Mirko Pham, Peter Nawroth, Martin Bendszus, Felix T Kurz. Ann Neurol 2018
42
11




Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the Diabetic Neuropathy Symptom score.
J W G Meijer, A J Smit, E V Sonderen, J W Groothoff, W H Eisma, T P Links. Diabet Med 2002
163
5

Whither pathogenetic treatments for diabetic polyneuropathy?
Andrew J M Boulton, Peter Kempler, Alexander Ametov, Dan Ziegler. Diabetes Metab Res Rev 2013
48
10

Glucose control and vascular complications in veterans with type 2 diabetes.
William Duckworth, Carlos Abraira, Thomas Moritz, Domenic Reda, Nicholas Emanuele, Peter D Reaven, Franklin J Zieve, Jennifer Marks, Stephen N Davis, Rodney Hayward,[...]. N Engl J Med 2009
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.